Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Wound Care ; 31(9): 780-791, 2022 Sep 02.
Article in English | MEDLINE | ID: mdl-36113542

ABSTRACT

OBJECTIVE: In this study, the effects of resveratrol topical ointment on wound contraction and histopathology of full-thickness cutaneous burn wounds were evaluated. METHOD: Adult albino rats were grouped into four equal-sized groups of 15 rats each, as follows: Group A-no wound, no treatment (control); Group B-1% silver sulphadiazine; Group C-5% resveratrol, and Group D-wound without treatment (control). A burn wound measuring 23.5mm was created on the skin at the dorsum of all rats in groups B-D after shaving. The percentage of wound contraction was measured using a digital Vernier Caliper on days 1, 3, 5, 7, 10, 14, 16, 18 and 21, post-wounding. From each group, five rats were then euthanised and tissue samples of the skin, liver and kidney were collected in 10% buffered formalin for histopathology. RESULTS: The percentage of wound contraction was significant (p<0.05) on 7, 14 and 18 days post treatment. Histopathologically, 5% resveratrol topical ointment application resulted in a thicker epidermis with neovascularisation and an increased collagen distribution. Resveratrol topical ointment ameliorated the extent of hepatocellular and nephrotubular injuries following burn-induced hepatocellular and acute kidney injuries. CONCLUSION: In this study, topical application of 5% resveratrol ointment appeared to enhance burn wound healing by increasing the rate of wound contraction through collagen fibre synthesis, granulation tissue formation and epithelial regeneration.


Subject(s)
Burns , Soft Tissue Injuries , Burns/therapy , Collagen/pharmacology , Formaldehyde/pharmacology , Humans , Ointments , Rats , Resveratrol/pharmacology , Silver Sulfadiazine/pharmacology , Silver Sulfadiazine/therapeutic use , Wound Healing
2.
Int J Med Mushrooms ; 16(6): 579-83, 2014.
Article in English | MEDLINE | ID: mdl-25404222

ABSTRACT

The antineuraminidase activity of different organic soluble fractions of Ganoderma lucidum extract was investigated using inhibition of hemagglutination and elution of chicken erythrocytes by Newcastle disease virus (NDV). Fractions of methanol, ethylacetate, and normal butanol (n-butanol) of the G. lucidum were tested against neuraminidase producing NDV as antigen. Different dilutions of the organic soluble fractions inhibited elution of 1% red blood cells by neuraminidase of NDV While the methanolic and n-butanol extracts inhibited neuraminidase activity even at a dilution of 1:16 and that of ethylacetate fraction inhibited even at 1:32 respectively. This finding indicates that G. lucidum has some antineuraminidase activity against NDV and may be exploited in the management of NDV infection.


Subject(s)
Ganoderma/chemistry , Methanol/chemistry , Neuraminidase/antagonists & inhibitors , Neuraminidase/metabolism , Newcastle disease virus/metabolism , Antiviral Agents/chemistry , Antiviral Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...